Posted in | News

Jacobs Bags New Rail Project in Hong Kong

Jacobs Engineering Group Inc. (NYSE: JEC) announced today that it received a contract from the Highways Department of the Government of the Hong Kong Special Administrative Region to provide engineering services for the construction, testing and commissioning phase of the Hong Kong section of the Guangzhou-Shenzhen-Hong Kong Express Rail Link (XRL).

The contract value is estimated at HK$83.8 million (approx US$10 million).

Jacobs' scope of work for the project includes monitoring and verification of the construction work that is executed by MTR Corporation Limited and its contractors. This is the follow-on contract to the design and site investigation phase services that Jacobs has been delivering since 2009. Jacobs' Hong Kong office will continue to work directly with the Railway Development Office of the Highways Department, which plans and coordinates the implementation of new rail projects in Hong Kong.

The Hong Kong section of the XRL will run in the form of a tunnel from a new terminus at West Kowloon to Huanggang in Shenzhen for connection with China's Mainland section. Construction has commenced and is expected to be complete in 2015.

In making the announcement, Jacobs Group Vice President Chris Nagel stated, "We have established a sound working relationship with the Railway Development Office of the Highways Department. We are pleased to be given this opportunity to further support the Government of the Hong Kong Special Administrative Region on this strategic infrastructure project to enhance Hong Kong's connectivity with Mainland China and help them maintain Hong Kong's position as the southern gateway to China."

Source: http://www.jacobs.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.